Success Metrics

Clinical Success Rate
89.4%

Based on 110 completed trials

Completion Rate
89%(110/123)
Active Trials
43(20%)
Results Posted
23%(25 trials)
Terminated
13(6%)

Phase Distribution

Ph phase_2
35
16%
Ph phase_4
16
8%
Ph phase_3
27
13%
Ph phase_1
32
15%
Ph early_phase_1
6
3%
Ph not_applicable
96
45%

Phase Distribution

38

Early Stage

35

Mid Stage

43

Late Stage

Phase Distribution212 total trials
Early Phase 1First-in-human
6(2.8%)
Phase 1Safety & dosage
32(15.1%)
Phase 2Efficacy & side effects
35(16.5%)
Phase 3Large-scale testing
27(12.7%)
Phase 4Post-market surveillance
16(7.5%)
N/ANon-phased studies
96(45.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.7%

110 of 124 finished

Non-Completion Rate

11.3%

14 ended early

Currently Active

43

trials recruiting

Total Trials

213

all time

Status Distribution
Active(67)
Completed(110)
Terminated(14)
Other(22)

Detailed Status

Completed110
Recruiting33
unknown20
Not yet recruiting17
Terminated13
Active, not recruiting10

Development Timeline

Analytics

Development Status

Total Trials
213
Active
43
Success Rate
89.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (2.8%)
Phase 132 (15.1%)
Phase 235 (16.5%)
Phase 327 (12.7%)
Phase 416 (7.5%)
N/A96 (45.3%)

Trials by Status

enrolling_by_invitation73%
completed11052%
recruiting3315%
active_not_recruiting105%
unknown209%
terminated136%
not_yet_recruiting178%
suspended21%
withdrawn10%

Recent Activity

Clinical Trials (213)

Showing 20 of 213 trialsScroll for more
NCT03291470Phase 3

Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee

Completed
NCT07143968Phase 2

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Recruiting
NCT07454915Phase 2

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Recruiting
NCT02690441Not Applicable

Physical Exercise Augmented CBT for GAD

Active Not Recruiting
NCT07150845Phase 2

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

Recruiting
NCT07546214Phase 1

A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.

Completed
NCT07533786Phase 2

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

Not Yet Recruiting
NCT07543016Not Applicable

Amino Acids and Exercise in FSHD

Recruiting
NCT07534657Phase 1

A Study of JPH034 in Healthy Adult Participants

Recruiting
NCT07531147Phase 4

Effects of Flurbiprofen Spray and Ice Cream for Pain and Voice Outcomes After Thyroidectomy

Not Yet Recruiting
NCT06873516Phase 2

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

Active Not Recruiting
NCT07498127Phase 2

Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study

Enrolling By Invitation
NCT07484061Not Applicable

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Recruiting
NCT07336615Not Applicable

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals

Enrolling By Invitation
NCT07466108Not Applicable

Hemodynamic Effects of Intravenous Paracetamol in Patients Undergoing Emergency Laparotomy

Recruiting
NCT07469228Phase 1

A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris

Completed
NCT07281703Phase 1

Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants

Recruiting
NCT07262281Phase 1

Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants

Recruiting
NCT07459829Phase 2

Study of CU06-1004 in Patients With Daibetic Macular Edema

Not Yet Recruiting
NCT07449000Not Applicable

Losartan for Corneal Fibrosis

Recruiting

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
213